Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myocardial Infarction Clinical Trials
Myocardial Infarction clinical trials are recruiting across 212 cities. Here are the cities with the most active studies:
About Myocardial Infarction
Myocardial infarction (heart attack) occurs when blood flow to a part of the heart muscle is blocked, causing tissue damage. It requires emergency treatment to restore blood flow. Long-term management includes dual antiplatelet therapy, statins, beta-blockers, and cardiac rehabilitation.
Clinical trials are advancing new treatments for myocardial infarction. Currently, 100 studies are recruiting a combined 723,255 participants across the United States. Research is being conducted by 83 organizations including ClinLogic LLC, Mayo Clinic, University of Massachusetts, Worcester and 80 others.
2026 Myocardial Infarction Research Landscape
As of July 2026, the myocardial infarction clinical trial landscape includes 100 actively recruiting studies across 212 cities in the United States. These studies are collectively seeking 723,255 participants, with an average enrollment target of 7,233 per study.
Research is being led by 83 different organizations, including ClinLogic LLC, Mayo Clinic, University of Massachusetts, Worcester, Medtronic, Children's National Research Institute, and 78 others. The large number of sponsors reflects significant research interest and investment in myocardial infarction treatment advancement.
Geographically, myocardial infarction trials are most concentrated in Los Angeles, California (22 trials); Phoenix, Arizona (15 trials); Washington D.C., District of Columbia (13 trials); Chicago, Illinois (12 trials); Boston, Massachusetts (11 trials) and 7 other cities.
Featured Myocardial Infarction Studies
Highlighted recruiting studies for myocardial infarction, selected by enrollment size and research scope.
Reduction of Adverse Drug Events and Readmissions
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
The REgistry of Very Early Estrogen and AnovuLation
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Social Needs Screening and Chronic Diseases Study (WE CARE)
The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it ...
Frequently Asked Questions About Myocardial Infarction Clinical Trials
Are there myocardial infarction clinical trials near me?
Yes, there are 100 myocardial infarction clinical trials currently recruiting across 212+ cities in the United States, including Los Angeles, California; Phoenix, Arizona; Washington D.C., District of Columbia. Browse the studies above to find one at a location convenient for you.
How do I join a myocardial infarction clinical trial?
To join a myocardial infarction clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myocardial infarction clinical trials free?
Yes, participation in myocardial infarction clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myocardial infarction treatments are being studied?
Current myocardial infarction clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 83 research organizations.
Is it safe to participate in myocardial infarction clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 13, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 13, 2026 · Data from ClinicalTrials.gov